Editas Medicine, Inc. $300,000,000 COMMON STOCK SALES AGREEMENTSales Agreement • May 14th, 2021 • Editas Medicine, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledMay 14th, 2021 Company Industry JurisdictionEditas Medicine, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cowen and Company, LLC (“Cowen”), as follows: